Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up

Alexander J. Stratigos; Aleksandar Sekulic; Ketty Peris; Oliver Bechter; Sorilla Prey; Karl D. Lewis; Nicole Basset-Seguin; Anne Lynn S. Chang; Stéphane Dalle; Almudena Fernández Orland; Lisa Licitra; Caroline Robert; Claas Ulrich; Axel Hauschild; Michael R. Migden; Reinhard Dummer; Suk Young Yoo; Emmanuel Okoye; Ioannis Bassukas; Carmen Loquai; Vincenzo De Giorgi; Zeynep Eroglu; Ralf Gutzmer; Jens Ulrich; Susana Puig; Timothy J. Inocencio; Chieh I. Chen; Patrick R. LaFontaine; Frank Seebach; Israel Lowy; Matthew G. Fury

doi:10.1016/j.jaad.2023.08.111

Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up

Alexander J. Stratigos, Aleksandar Sekulic, Ketty Peris, Oliver Bechter, Sorilla Prey, Karl D. Lewis, Nicole Basset-Seguin, Anne Lynn S. Chang, Stéphane Dalle, Almudena Fernández Orland, Lisa Licitra, Caroline Robert, Claas Ulrich, Axel Hauschild, Michael R. Migden, Reinhard Dummer, Suk Young Yoo, Emmanuel Okoye, Ioannis Bassukas, Carmen LoquaiVincenzo De Giorgi, Zeynep Eroglu, Ralf Gutzmer, Jens Ulrich, Susana Puig, Timothy J. Inocencio, Chieh I. Chen, Patrick R. LaFontaine, Frank Seebach, Israel Lowy, Matthew G. Fury

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	414-418
Number of pages	5
Journal	Journal of the American Academy of Dermatology
Volume	90
Issue number	2
DOIs	https://doi.org/10.1016/j.jaad.2023.08.111
Publication status	Published - 1 Feb 2024

Keywords

cemiplimab
clinical trial
hedgehog inhibitor
immune checkpoint inhibitor
locally advanced basal cell carcinoma
phase 2
quality of life

Access to Document

10.1016/j.jaad.2023.08.111

Cite this

Stratigos, A. J., Sekulic, A., Peris, K., Bechter, O., Prey, S., Lewis, K. D., Basset-Seguin, N., Chang, A. L. S., Dalle, S., Fernández Orland, A., Licitra, L., Robert, C., Ulrich, C., Hauschild, A., Migden, M. R., Dummer, R., Yoo, S. Y., Okoye, E., Bassukas, I., ... Fury, M. G. (2024). Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up. Journal of the American Academy of Dermatology, 90(2), 414-418. https://doi.org/10.1016/j.jaad.2023.08.111

@article{d0bc6ff1a049414e8d5f2ba8a123908d,

title = "Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up",

keywords = "cemiplimab, clinical trial, hedgehog inhibitor, immune checkpoint inhibitor, locally advanced basal cell carcinoma, phase 2, quality of life",

author = "Stratigos, {Alexander J.} and Aleksandar Sekulic and Ketty Peris and Oliver Bechter and Sorilla Prey and Lewis, {Karl D.} and Nicole Basset-Seguin and Chang, {Anne Lynn S.} and St{\'e}phane Dalle and {Fern{\'a}ndez Orland}, Almudena and Lisa Licitra and Caroline Robert and Claas Ulrich and Axel Hauschild and Migden, {Michael R.} and Reinhard Dummer and Yoo, {Suk Young} and Emmanuel Okoye and Ioannis Bassukas and Carmen Loquai and {De Giorgi}, Vincenzo and Zeynep Eroglu and Ralf Gutzmer and Jens Ulrich and Susana Puig and Inocencio, {Timothy J.} and Chen, {Chieh I.} and LaFontaine, {Patrick R.} and Frank Seebach and Israel Lowy and Fury, {Matthew G.}",

year = "2024",

month = feb,

day = "1",

doi = "10.1016/j.jaad.2023.08.111",

language = "English",

volume = "90",

pages = "414--418",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

number = "2",

}

Stratigos, AJ, Sekulic, A, Peris, K, Bechter, O, Prey, S, Lewis, KD, Basset-Seguin, N, Chang, ALS, Dalle, S, Fernández Orland, A, Licitra, L, Robert, C, Ulrich, C, Hauschild, A, Migden, MR, Dummer, R, Yoo, SY, Okoye, E, Bassukas, I, Loquai, C, De Giorgi, V, Eroglu, Z, Gutzmer, R, Ulrich, J, Puig, S, Inocencio, TJ, Chen, CI, LaFontaine, PR, Seebach, F, Lowy, I & Fury, MG 2024, 'Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up', Journal of the American Academy of Dermatology, vol. 90, no. 2, pp. 414-418. https://doi.org/10.1016/j.jaad.2023.08.111

Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up. / Stratigos, Alexander J.; Sekulic, Aleksandar; Peris, Ketty et al.
In: Journal of the American Academy of Dermatology, Vol. 90, No. 2, 01.02.2024, p. 414-418.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy

T2 - Extended follow-up

AU - Stratigos, Alexander J.

AU - Sekulic, Aleksandar

AU - Peris, Ketty

AU - Bechter, Oliver

AU - Prey, Sorilla

AU - Lewis, Karl D.

AU - Basset-Seguin, Nicole

AU - Chang, Anne Lynn S.

AU - Dalle, Stéphane

AU - Fernández Orland, Almudena

AU - Licitra, Lisa

AU - Robert, Caroline

AU - Ulrich, Claas

AU - Hauschild, Axel

AU - Migden, Michael R.

AU - Dummer, Reinhard

AU - Yoo, Suk Young

AU - Okoye, Emmanuel

AU - Bassukas, Ioannis

AU - Loquai, Carmen

AU - De Giorgi, Vincenzo

AU - Eroglu, Zeynep

AU - Gutzmer, Ralf

AU - Ulrich, Jens

AU - Puig, Susana

AU - Inocencio, Timothy J.

AU - Chen, Chieh I.

AU - LaFontaine, Patrick R.

AU - Seebach, Frank

AU - Lowy, Israel

AU - Fury, Matthew G.

PY - 2024/2/1

Y1 - 2024/2/1

KW - cemiplimab

KW - clinical trial

KW - hedgehog inhibitor

KW - immune checkpoint inhibitor

KW - locally advanced basal cell carcinoma

KW - phase 2

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=85177063925&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2023.08.111

DO - 10.1016/j.jaad.2023.08.111

M3 - Article

C2 - 37839734

AN - SCOPUS:85177063925

SN - 0190-9622

VL - 90

SP - 414

EP - 418

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 2

ER -

Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up

Keywords

Access to Document

Other files and links

Cite this